EMEA — Net Sales
Stryker EMEA — Net Sales remained flat by 0.0% to $724.25M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $654.50M to $724.25M. Over 3 years (FY 2021 to FY 2024), EMEA — Net Sales shows an upward trend with a 8.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests growing market share or higher demand for medical products in the region, while a decrease may signal competitive pressure or economic headwinds.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices, equipment, and services within the...
Peer comparison
Comparable to regional revenue reporting by global medical device peers, often benchmarked against regional GDP growth and healthcare spending trends.
syk_segment_europe_middle_east_africa_net_salesHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $2.30B | $2.35B | $2.62B | $2.90B |
| YoY Change | — | +2.1% | +11.5% | +10.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's emea — net sales?
- Stryker (SYK) reported emea — net sales of $724.25M in Q4 2024.
- How has Stryker's emea — net sales changed year-over-year?
- Stryker's emea — net sales increased by 10.7% year-over-year, from $654.50M to $724.25M.
- What is the long-term trend for Stryker's emea — net sales?
- Over 3 years (2021 to 2024), Stryker's emea — net sales has grown at a 8.0% compound annual growth rate (CAGR), from $2.30B to $2.90B.
- What does emea — net sales mean?
- The total revenue earned from customers located in the Europe, Middle East, and Africa region.